A digital tool to help reduce cravings in people with opioid use disorder.
BoostPrime, A Novel Digital Therapeutic for Craving Mitigation in OUD
['FUNDING_SBIR_2'] · NXTECH INC · NIH-11261972
This study is testing a new smartphone app called BoostPrime that helps people with opioid use disorder manage their cravings better by using fun exercises to boost self-control, making it easier to stick to their treatment plans.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NXTECH INC (nih funded) |
| Locations | 1 site (Houston, UNITED STATES) |
| Trial ID | NIH-11261972 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a smartphone-based intervention called BoostPrime, designed to help individuals with opioid use disorder (OUD) manage their cravings more effectively. The program incorporates cognitive training exercises aimed at enhancing self-control and reducing the intensity of cravings experienced by patients, even those undergoing medication-assisted treatment. By refining the software's interface and conducting large-scale testing, the research aims to create a user-friendly tool that can be integrated into existing treatment plans for OUD. Patients will be able to access this digital therapeutic to receive real-time support for craving management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are currently receiving medication-assisted treatment.
Not a fit: Patients who are not diagnosed with opioid use disorder or those not undergoing any form of treatment for substance use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a powerful tool to better manage cravings and improve their chances of recovery from opioid use disorder.
How similar studies have performed: Other research has shown promise in using digital therapeutics for managing cravings in substance use disorders, indicating that this approach could be effective.
Where this research is happening
Houston, UNITED STATES
- NXTECH INC — Houston, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PATEL, SALIL — NXTECH INC
- Study coordinator: PATEL, SALIL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.